SNESBasic Materials · Specialty ChemicalsThe 1 Wall Street analysts covering SenesTech, Inc. hold a median 12-month price target of $6.75 — +457.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 27 of 100 as at 22 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores SenesTech, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (95): Smaller than most of the companies we track.
Value (7): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on SNES, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +457.9% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 Dec 2024 | HC Wainwright & Co. | Reiterates | Buy | $3.50 → $10 |
| 12 Dec 2024 | HC Wainwright & Co. | Maintains | Buy | $3.50 → $10 |
| 14 May 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 28 Dec 2023 | HC Wainwright & Co. | Maintains | Buy | — |
| 24 May 2023 | HC Wainwright & Co. | Reiterates | Buy | $4.00 |
| 18 Apr 2023 | HC Wainwright & Co. | Reiterates | Buy | $4.00 |
| 20 Jan 2021 | HC Wainwright & Co. | Initiates | Buy | $4.00 |
| 25 Nov 2020 | Craig-Hallum | Initiates | Buy | — |
| 4 Jan 2017 | Craig-Hallum | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SNES appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 74% of US stocks
Cheaper than 44% of US stocks
Cheaper than 78% of US stocks
Cheaper than 64% of US stocks
Higher than 73% of US stocks
Higher than 62% of US stocks
Higher than 86% of US stocks
Higher than 10% of US stocks
Higher than 1% of US stocks
Higher than 12% of US stocks
Higher than 9% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own SenesTech, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
SenesTech announced it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, held virtually on August 18, 2026.
Why it matters — The investor summit webcast gives SenesTech a platform to present its business to investors, which SNES watchers may follow for company visibility.
SenesTech, Inc. held its Q2 2026 earnings call, and a transcript of the call has been published by Seeking Alpha. The transcript presents the company's quarterly earnings discussion as reported during the call.
Why it matters — For SNES watchers, this transcript provides the full record of management's Q2 2026 earnings discussion and their commentary during the call.
SenesTech reported record Q2 2026 revenue, up 56% sequentially, with a company-record gross margin of 73.6%, in the first full quarter of in-house Amazon management. The results advance the company's intended shift to a scalable, recurring-revenue platform.
Why it matters — The record revenue and gross margin in the first full quarter of in-house Amazon management mark early progress on SenesTech's shift toward a scalable, recurring-revenue platform.
SenesTech has introduced new assessment services that help B2B customers better understand and evaluate rodent infestations, complementing the company's existing implementation and deployment services.
Why it matters — The expanded service offering could help SenesTech develop more customized solutions for clients, potentially strengthening B2B customer relationships and differentiating the company's approach to rodent management.
SenesTech reported that its active subscriber base more than doubled, attributing the growth to its integrated e-commerce strategy. The company said the strategy is driving recurring revenue and supporting long-term growth across consumer and business-to-business markets.
Why it matters — A SNES watcher would care because subscriber growth and recurring revenue from e-commerce suggest expanding demand across both consumer and B2B channels.
The 1 Wall Street analysts covering SenesTech, Inc. have a median 12-month price target of $6.75, with estimates ranging from $3.5 to $10. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering SenesTech, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SenesTech, Inc. 27 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Aug 2026, SenesTech, Inc. ranks 27 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (95 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies +457.9% from the last close, and Ticker Nerd's factor model ranks SenesTech, Inc. 27 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering SenesTech, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SNES are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3.5 to $10 over the next 12 months.
SenesTech, Inc. returned -73.1% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
SenesTech Inc. is a biotechnology company specializing in the development and commercialization of fertility control technologies for humane management of animal pest populations, particularly rodents.
The most recent item we track (PRNewsWire, 17 Aug 2026): "SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026". SenesTech announced it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, held virtually on August 18, 2026.
SenesTech Inc. is a biotechnology company specializing in the development and commercialization of fertility control technologies for humane management of animal pest populations, particularly rodents. Its primary products include ContraPest, a liquid bait with active ingredients 4-vinylcyclohexene diepoxide and triptolide that serves as the only U.S. EPA-registered contraceptive for both male and female rats, and Evolve, a soft bait featuring cottonseed oil that limits reproduction in rats from the first breeding cycles after consumption. The company also offers Evolve Mouse, an adapted version targeting male and female mice after one to two breeding cycles. These products integrate into comprehensive integrated pest management programs, providing non-lethal alternatives to traditional rodenticides for urban, commercial, warehousing, and municipal applications. SenesTech Inc. supports global distribution efforts, including partnerships in regions like Indonesia, New Zealand, Belize, and Australia, alongside direct-to-consumer e-commerce channels such as Amazon. Additionally, it provides teleconsulting and technical advisory services to optimize pest control strategies. Founded in 2004 and headquartered in Phoenix, Arizona, SenesTech Inc. focuses on sustainable, environmentally friendly solutions for pest management across residential, business, and public sectors.
CEO Mr. Michael Edell · 23 employees · United States · https://www.senestech.com